CoChat

Contra‐indications to metformin therapy are largely disregarded

Holstein, A., Nahrwold, D., Hinze, S., Egberts, E. ‐H. · 1999 · Diabetic Medicine
Cited by 132

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Summary: Aims To investigate the current metformin treatment practice and in particular to examine the consideration given to its contraindications. Methods A cross‐sectional analysis of 308 consecutive Type 2 diabetic patients (mean age 66 ± 11.3 years) previously treated with metformin on an outpatient basis and admitted to a German general hospital during the period from 1 January 1995 to 31 May 1998 because of acute disease or in order to optimize their diabetes management. All patients underwent a basic investigation comprising a documentation of their medical history, a physical examination, an electrocardiogram, and an extensive laboratory profile; 34% also had acute coronary angiography. Results On admission to hospital, 73% of the patients were found to have contra‐indications, risk factors, or intercurrent illnesses necessitating discontinuation of metformin; 51% of these patients had several of these conditions. As major contra‐indications to metformin, renal impairment was present in 19% of all patients, heart failure in 25%, respiratory insufficiency in 6.5%, and hepatic impairment in 1.3%. The risk factors to metformin included advanced coronary heart disease in 51%, atrial fibrillation in 9.8%, chronic alcohol abuse in 3.3%, advanced peripheral vascular disease in 2%, and pregnancy in 0.7%. As intercurrent illnesses, cerebral ischaemia occurred in 9.8% under metformin treatment and malignancies were diagnosed in 6.5%. The patients with contra‐indications or requiring caution to metformin were significantly older and had previously been treated with more cardiovascular medication than those without such reservations (P < 0.001). Conclusions Despite the considerable risk of lactic acidosis in the majority of patients, no cases were observed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1464-5491.1999.00115.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 132

Metadata

Authors
Holstein, A., Nahrwold, D., Hinze, S., & Egberts, E. ‐.
Venue
Diabetic Medicine
Publisher
Wiley
Published
1999-08
Volume
16
Issue
8
Pages
692-696
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2049554771
Cited by
132
References
5
FWCI
3.40
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Contra‐indications to metformin therapy are largely disregarded. https://app.cochat.ai/papers/10.1046/j.1464-5491.1999.00115.x
The paper
Holstein, A., Nahrwold, D., Hinze, S., & Egberts, E. ‐. (1999). Contra‐indications to metformin therapy are largely disregarded. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.1999.00115.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.